Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To assess the Dai Dai flower extract on body weight control
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo drink | Placebo Comparator |
| |
| Dai Dai flower drink | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placebo drink | Dietary Supplement | consume 1 bottle (50 mL) per day for 8 weeks |
| |
| Measure | Description | Time Frame |
|---|---|---|
| The change of body weight | The body weight (kg) was assessed by InBody. | Change from Baseline body weight at 8 weeks |
| The change of BMI | The BMI was assessed by InBody. | Change from Baseline BMI at 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| The change of body fat mass | The body fat mass (kg) was assessed by InBody. | Change from Baseline body fat mass at 8 weeks |
| The change of visceral fat mass | The visceral fat mass (kg) was assessed by InBody. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hsiu-Mei Chiang, Prof. | China Medical University, China | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| China Medical University | Taichung | 404 | Taiwan |
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dai Dai flower drink |
| Dietary Supplement |
consume 1 bottle (50 mL) per day for 8 weeks |
|
| Change from Baseline visceral fat mass at 8 weeks |
| The change of waist-hip ratio | The waist-hip ratio was assessed by measuring tape. | Change from Baseline waist-hip ratio at 8 weeks |
| The change of basal metabolic rate | The basal metabolic rate was assessed by InBody. | Change from Baseline basal metabolic rate at 8 weeks |
| The change of AST | Venous blood was sampled to measure concentrations of aspartate transaminase (AST) | Change from Baseline AST at 8 weeks |
| The change of ALT | Venous blood was sampled to measure concentrations of alanine aminotransferase (ALT) | Change from Baseline ALT at 8 weeks |
| The change of Creatinine | Venous blood was sampled to measure concentrations of creatinine | Change from Baseline creatinine at 8 weeks |
| The change of BUN | Venous blood was sampled to measure concentrations of blood urea nitrogen (BUN) | Change from Baseline BUN at 8 weeks |
| The change of fasting glycemia | Venous blood was sampled to measure concentrations of fasting glycemia | Change from Baseline fasting glycemia at 8 weeks |
| The change of total cholesterol | Venous blood was sampled to measure concentrations of total cholesterol | Change from Baseline total cholesterol at 8 weeks |
| The change of triglyceride | Venous blood was sampled to measure concentrations of triglyceride | Change from Baseline triglyceride at 8 weeks |
| The change of HDL-cholesterol | Venous blood was sampled to measure concentrations of HDL-cholesterol | Change from Baseline HDL-cholesterol at 8 weeks |
| The change of LDL-cholesterol | Venous blood was sampled to measure concentrations of LDL-cholesterol | Change from Baseline LDL-cholesterol at 8 weeks |
| The change of insulin | Venous blood was sampled to measure concentrations of insulin | Change from Baseline insulin at 8 weeks |
| The change of adiponectin | Venous blood was sampled to measure concentrations of adiponectin | Change from Baseline adiponectin at 8 weeks |
| The change of leptin | Venous blood was sampled to measure concentrations of leptin | Change from Baseline leptin at 8 weeks |
| The change of IFN-γ | Venous blood was sampled to measure concentrations of IFN-γ | Change from Baseline IFN-γ at 8 weeks |
| The change of IL-2 | Venous blood was sampled to measure concentrations of IL-2 | Change from Baseline IL-2 at 8 weeks |
| The change of IL-1beta | Venous blood was sampled to measure concentrations of IL-1beta | Change from Baseline IL-1beta at 8 weeks |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |